These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31428662)

  • 41. Regulatory T cells: the ultimate HIV reservoir?
    Rocco J; Mellors JW; Macatangay BJ
    J Virus Erad; 2018 Oct; 4(4):209-214. PubMed ID: 30515299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen.
    Ferreira RC; Reynolds SJ; Capoferri AA; Baker O; Brown EE; Klock E; Miller J; Lai J; Saraf S; Kirby C; Lynch B; Hackman J; Gowanlock SN; Tomusange S; Jamiru S; Anok A; Kityamuweesi T; Buule P; Bruno D; Martens C; Rose R; Lamers SL; Galiwango RM; Poon AFY; Quinn TC; Prodger JL; Redd AD
    medRxiv; 2023 May; ():. PubMed ID: 37292785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring the contribution of γδ T cells to the persistent HIV reservoir.
    James KS; Trumble I; Clohosey ML; Moeser M; Roan NR; Adimora AA; Joseph SB; Archin NM; Hudgens M; Soriano-Sarabia N
    AIDS; 2020 Mar; 34(3):363-371. PubMed ID: 31764074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Latent Human Immunodeficiency Virus (HIV) Reservoir Resides Primarily in CD32-CD4+ T Cells in Perinatally HIV-Infected Adolescents With Long-Term Virologic Suppression.
    Dhummakupt A; Siems LV; Singh D; Chen YH; Anderson T; Collinson-Streng A; Zhang H; Patel P; Agwu A; Persaud D
    J Infect Dis; 2019 Jan; 219(1):80-88. PubMed ID: 30053296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA.
    Lungu C; Banga R; Gruters RA; Procopio FA
    Front Microbiol; 2021; 12():686690. PubMed ID: 34211450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measuring the latent reservoir in vivo.
    Massanella M; Richman DD
    J Clin Invest; 2016 Feb; 126(2):464-72. PubMed ID: 26829625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
    Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth.
    Kiselinova M; De Spiegelaere W; Buzon MJ; Malatinkova E; Lichterfeld M; Vandekerckhove L
    PLoS Pathog; 2016 Mar; 12(3):e1005472. PubMed ID: 26938995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.
    Bruner KM; Wang Z; Simonetti FR; Bender AM; Kwon KJ; Sengupta S; Fray EJ; Beg SA; Antar AAR; Jenike KM; Bertagnolli LN; Capoferri AA; Kufera JT; Timmons A; Nobles C; Gregg J; Wada N; Ho YC; Zhang H; Margolick JB; Blankson JN; Deeks SG; Bushman FD; Siliciano JD; Laird GM; Siliciano RF
    Nature; 2019 Feb; 566(7742):120-125. PubMed ID: 30700913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
    Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Charlins P; Schmitt K; Remling-Mulder L; Hogan LE; Hanhauser E; Hobbs KS; Hecht F; Deeks SG; Henrich TJ; Akkina R
    Virology; 2017 Jul; 507():135-139. PubMed ID: 28432928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution.
    Zhang W; Svensson Akusjärvi S; Sönnerborg A; Neogi U
    Front Microbiol; 2018; 9():2358. PubMed ID: 30333813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
    Rong L; Perelson AS
    PLoS Comput Biol; 2009 Oct; 5(10):e1000533. PubMed ID: 19834532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells.
    Yuan Z; Kang G; Lu W; Li Q
    J Virus Erad; 2017 Jan; 3(1):61-65. PubMed ID: 28275460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.